IDO1 and paracoccidioidomycosis: Our previous findings demonstrating the important role of the IDO/AhR/Treg/Th17 axis in the control of pulmonary PCM led us to comparatively investigate the immunomodulatory effect of two different agonists and one antagonist of AhR signaling.